Difference between revisions of "Adrenal cortical adenoma"
Jump to navigation
Jump to search
(+cat.) |
m (fix sp wikify) |
||
(10 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ Infobox diagnosis | |||
| Name = {{PAGENAME}} | |||
| Image = Primary aldosteronism (1) adrenocortical adenoma.jpg | |||
| Width = | |||
| Caption = Adrenal cortical adenoma. [[H&E stain]]. | |||
| Synonyms = | |||
| Micro = | |||
| Subtypes = | |||
| LMDDx = adrenal cortical nodule, [[adrenal cortical hyperplasia]], [[adrenal cortical carcinoma]] | |||
| Stains = | |||
| IHC = [[calretinin]], inhibin | |||
| EM = | |||
| Molecular = | |||
| IF = | |||
| Gross = | |||
| Grossing = | |||
| Site = [[adrenal gland]] | |||
| Assdx = | |||
| Syndromes = | |||
| Clinicalhx = | |||
| Signs = | |||
| Symptoms = | |||
| Prevalence = relatively common | |||
| Bloodwork = | |||
| Rads = adrenal mass, HU<10 | |||
| Endoscopy = | |||
| Prognosis = benign | |||
| Other = | |||
| ClinDDx = | |||
| Tx = followup or surgical excision | |||
}} | |||
'''Adrenal cortical adenoma''', also '''adrenocortical adenoma''' and '''adrenal adenoma''', is a relatively common benign pathology of the [[adrenal gland]]. | |||
==General== | |||
Epidemiology: | |||
*Often an incidental finding. | |||
Pathologic/clinical: | |||
*May be hormonally active. | |||
*Can be a cause of [[hypertension]].<ref name=pmid18584586/> | |||
*Radiologists are good at identifying adenomas, as they are usually lipid rich and have a characteristic low HU signal (<10 HU<ref name=pmid24636681>{{Cite journal | last1 = Tenenbaum | first1 = F. | last2 = Lataud | first2 = M. | last3 = Groussin | first3 = L. | title = [Update in adrenal imaging]. | journal = Presse Med | volume = 43 | issue = 4 Pt 1 | pages = 410-9 | month = Apr | year = 2014 | doi = 10.1016/j.lpm.2014.02.002 | PMID = 24636681 }}</ref>). | |||
**Microadenomas may be missed.<ref name=pmid18584586/><ref name=pmid20881759>{{Cite journal | last1 = Fujiwara | first1 = M. | last2 = Murao | first2 = K. | last3 = Imachi | first3 = H. | last4 = Yoshida | first4 = K. | last5 = Muraoka | first5 = T. | last6 = Ohyama | first6 = T. | last7 = Kushida | first7 = Y. | last8 = Haba | first8 = R. | last9 = Kakehi | first9 = Y. | title = Misdiagnosis of two cases of primary aldosteronism owing to failure of computed tomography to detect adrenal microadenoma. | journal = Am J Med Sci | volume = 340 | issue = 4 | pages = 335-7 | month = Oct | year = 2010 | doi = 10.1097/MAJ.0b013e3181e95587 | PMID = 20881759 }}</ref> | |||
Indications for excision:<ref name=pmid10870039>{{Cite journal | last1 = Luton | first1 = JP. | last2 = Martinez | first2 = M. | last3 = Coste | first3 = J. | last4 = Bertherat | first4 = J. | title = Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center. | journal = Eur J Endocrinol | volume = 143 | issue = 1 | pages = 111-7 | month = Jul | year = 2000 | doi = | PMID = 10870039 }} | |||
</ref><ref name=pmid19035218>{{Cite journal | last1 = Liu | first1 = XK. | last2 = Liu | first2 = XJ. | last3 = Dong | first3 = X. | last4 = Kong | first4 = CZ. | title = [Clinical research about treatment for adrenal incidentalomas] | journal = Zhonghua Wai Ke Za Zhi | volume = 46 | issue = 11 | pages = 832-4 | month = Jun | year = 2008 | doi = | PMID = 19035218 }}</ref> | |||
*Lesions >30 mm. | |||
*Hormonally active. | |||
*Non-incidental finding. (???) | |||
*Adrenal vein sampling (AVS) suggestive of adenoma.<ref name=pmid18584586>{{Cite journal | last1 = Myint | first1 = KS. | last2 = Watts | first2 = M. | last3 = Appleton | first3 = DS. | last4 = Lomas | first4 = DJ. | last5 = Jamieson | first5 = N. | last6 = Taylor | first6 = KP. | last7 = Coghill | first7 = S. | last8 = Brown | first8 = MJ. | title = Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension. | journal = J Renin Angiotensin Aldosterone Syst | volume = 9 | issue = 2 | pages = 103-6 | month = Jun | year = 2008 | doi = 10.3317/jraas.2008.015 | PMID = 18584586 }}</ref> | |||
Notes: | |||
*[[Cushing disease]] is due to the ACTH over-production by the [[pituitary]]. | |||
*In cortisol producing tumours (''Cushing syndrome''): atrophy of the non-hyperplastic cortex (due to feedback inhibition from the [[pituitary gland]]). | |||
==Microscopic== | |||
Classic features: | |||
*Well-defined cell borders. | |||
*Clear cells (abundant, finely vacuolated cytoplasm) | |||
*Polygonal pink cells. | |||
*Most of the nuclei are bland, central and round. | |||
*May have foci of [[necrosis]]/degeneration and nuclear atypia. | |||
Note: | |||
*In aldosterone producing tumours: | |||
**May extend outside of the capsule (should ''not'' be diagnosed as ''[[adrenal cortical carcinoma]]''). | |||
**No atrophy of non-hyperplastic cortex. | |||
**May show spironolactone bodies if hypertension treated with spironolactone prior to surgery. | |||
DDx: | |||
*Adrenal cortical nodule.<ref name=Ref_EP200>{{Ref EP|200}}</ref> | |||
*[[Adrenal cortical hyperplasia]]. | |||
**Hyperplasia is multifocal.<ref>IAV. 18 February 2009.</ref> | |||
*[[Adrenal cortical carcinoma]] - see ''Weiss criteria'' below. | |||
====Weiss criteria==== | |||
The diagnosis of ''adrenal cortical carcinoma'' requires three of the following:<ref name=pmid20551521>{{cite journal |author=Jain M, Kapoor S, Mishra A, Gupta S, Agarwal A |title=Weiss criteria in large adrenocortical tumors: a validation study |journal=Indian J Pathol Microbiol |volume=53 |issue=2 |pages=222–6 |year=2010 |pmid=20551521 |doi=10.4103/0377-4929.64325 |url=}}</ref><ref name=pmid6703192>{{Cite journal | last1 = Weiss | first1 = LM. | title = Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. | journal = Am J Surg Pathol | volume = 8 | issue = 3 | pages = 163-9 | month = Mar | year = 1984 | doi = | PMID = 6703192 }}</ref> | |||
#High nuclear grade. | |||
#High mitotic rate; >5/50 HPF (@ 40X obj.) - definition suffers from [[HPFitis]]. | |||
#Atypical mitoses. | |||
#Cleared cytoplasm in <= 25% of tumour cells. | |||
#Sheeting (diffuse architecture) in >= 1/3 of tumour cells. | |||
#Necrosis in nests. | |||
#Venous invasion. | |||
#Adrenal sinusoid invasion; [[lymphovascular space invasion]] within the [[adrenal gland]]. | |||
#Capsular invasion. | |||
===Images=== | |||
<gallery> | |||
Image: Adrenal CorticalAdenoma DSCN5001 PA.JPG|Adrenal Cortical Adenoma (SKB) | |||
Image: Adrenal CorticalAdenoma DSCN5002 PA.JPG|Adrenal Cortical Adenoma (SKB) | |||
Image: Adrenal CorticalAdenoma DSCN5004 PA.JPG|Adrenal Cortical Adenoma (SKB) | |||
Image: Adrenal CorticalAdenoma DSCN5005 PA.JPG|Adrenal Cortical Adenoma (SKB) | |||
Image: Adrenal CorticalAdenoma MP CTR.jpg|Adrenal Cortical Adenoma - Medium power (SKB) | |||
Image: Adrenal CorticalAdenoma HP CTR.jpg|Adrenal Cortical Adenoma - High power. Abundant clear cytoplasm. Round, regular nuclei. (SKB) | |||
Image: Adrenal CorticalAdenoma MP PA.JPG|Adrenal Cortical Adenoma - Some pleomorphism - Medium power (SKB) | |||
Image: Adrenal LipoAdenoma MP PA.JPG|Adrenal cortical adenoma with fat - "lipoadenoma" (SKB) | |||
</gallery> | |||
==IHC== | |||
Features:<ref name=pmid11893039>{{cite journal |authors=Jorda M, De MB, Nadji M |title=Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=1 |pages=67–70 |date=March 2002 |pmid=11893039 |doi=10.1097/00129039-200203000-00012 |url=}}</ref> | |||
*[[Calretinin]] +ve. | |||
*Inhibin +ve. | |||
Note: | |||
*Calretinin and inhibin in combination are useful for adrenal versus [[pheochromocytoma]].<ref name=pmid11893039/> | |||
==Sign out== | |||
<pre> | |||
Adrenal Gland, Right, Adrenalectomy: | |||
- Adrenal cortical adenoma. | |||
</pre> | |||
===Microscopic=== | |||
<pre> | |||
The sections show a benign adrenal gland with an expanded cortex. | |||
Clearing of the cytoplasm is present in the cortex. | |||
None of the following are present in the cortex: | |||
High nuclear grade, high mitotic rate (mitotic activity 1/50 HPF, | |||
where 1 HPF~=0.2376 mm*mm), atypical mitoses, sheeting, necrosis, | |||
sinusoidal invasion, venous invasion, capsular invasion. | |||
</pre> | |||
==See also== | |||
*[[Adrenal gland]]. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Adrenal gland]] | |||
[[Category:Diagnosis]] | [[Category:Diagnosis]] |
Latest revision as of 14:38, 1 June 2020
Adrenal cortical adenoma | |
---|---|
Diagnosis in short | |
Adrenal cortical adenoma. H&E stain. | |
LM DDx | adrenal cortical nodule, adrenal cortical hyperplasia, adrenal cortical carcinoma |
IHC | calretinin, inhibin |
Site | adrenal gland |
| |
Prevalence | relatively common |
Radiology | adrenal mass, HU<10 |
Prognosis | benign |
Treatment | followup or surgical excision |
Adrenal cortical adenoma, also adrenocortical adenoma and adrenal adenoma, is a relatively common benign pathology of the adrenal gland.
General
Epidemiology:
- Often an incidental finding.
Pathologic/clinical:
- May be hormonally active.
- Can be a cause of hypertension.[1]
- Radiologists are good at identifying adenomas, as they are usually lipid rich and have a characteristic low HU signal (<10 HU[2]).
Indications for excision:[4][5]
- Lesions >30 mm.
- Hormonally active.
- Non-incidental finding. (???)
- Adrenal vein sampling (AVS) suggestive of adenoma.[1]
Notes:
- Cushing disease is due to the ACTH over-production by the pituitary.
- In cortisol producing tumours (Cushing syndrome): atrophy of the non-hyperplastic cortex (due to feedback inhibition from the pituitary gland).
Microscopic
Classic features:
- Well-defined cell borders.
- Clear cells (abundant, finely vacuolated cytoplasm)
- Polygonal pink cells.
- Most of the nuclei are bland, central and round.
- May have foci of necrosis/degeneration and nuclear atypia.
Note:
- In aldosterone producing tumours:
- May extend outside of the capsule (should not be diagnosed as adrenal cortical carcinoma).
- No atrophy of non-hyperplastic cortex.
- May show spironolactone bodies if hypertension treated with spironolactone prior to surgery.
DDx:
- Adrenal cortical nodule.[6]
- Adrenal cortical hyperplasia.
- Hyperplasia is multifocal.[7]
- Adrenal cortical carcinoma - see Weiss criteria below.
Weiss criteria
The diagnosis of adrenal cortical carcinoma requires three of the following:[8][9]
- High nuclear grade.
- High mitotic rate; >5/50 HPF (@ 40X obj.) - definition suffers from HPFitis.
- Atypical mitoses.
- Cleared cytoplasm in <= 25% of tumour cells.
- Sheeting (diffuse architecture) in >= 1/3 of tumour cells.
- Necrosis in nests.
- Venous invasion.
- Adrenal sinusoid invasion; lymphovascular space invasion within the adrenal gland.
- Capsular invasion.
Images
IHC
Features:[10]
- Calretinin +ve.
- Inhibin +ve.
Note:
- Calretinin and inhibin in combination are useful for adrenal versus pheochromocytoma.[10]
Sign out
Adrenal Gland, Right, Adrenalectomy: - Adrenal cortical adenoma.
Microscopic
The sections show a benign adrenal gland with an expanded cortex. Clearing of the cytoplasm is present in the cortex. None of the following are present in the cortex: High nuclear grade, high mitotic rate (mitotic activity 1/50 HPF, where 1 HPF~=0.2376 mm*mm), atypical mitoses, sheeting, necrosis, sinusoidal invasion, venous invasion, capsular invasion.
See also
References
- ↑ 1.0 1.1 1.2 Myint, KS.; Watts, M.; Appleton, DS.; Lomas, DJ.; Jamieson, N.; Taylor, KP.; Coghill, S.; Brown, MJ. (Jun 2008). "Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.". J Renin Angiotensin Aldosterone Syst 9 (2): 103-6. doi:10.3317/jraas.2008.015. PMID 18584586.
- ↑ Tenenbaum, F.; Lataud, M.; Groussin, L. (Apr 2014). "[Update in adrenal imaging].". Presse Med 43 (4 Pt 1): 410-9. doi:10.1016/j.lpm.2014.02.002. PMID 24636681.
- ↑ Fujiwara, M.; Murao, K.; Imachi, H.; Yoshida, K.; Muraoka, T.; Ohyama, T.; Kushida, Y.; Haba, R. et al. (Oct 2010). "Misdiagnosis of two cases of primary aldosteronism owing to failure of computed tomography to detect adrenal microadenoma.". Am J Med Sci 340 (4): 335-7. doi:10.1097/MAJ.0b013e3181e95587. PMID 20881759.
- ↑ Luton, JP.; Martinez, M.; Coste, J.; Bertherat, J. (Jul 2000). "Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center.". Eur J Endocrinol 143 (1): 111-7. PMID 10870039.
- ↑ Liu, XK.; Liu, XJ.; Dong, X.; Kong, CZ. (Jun 2008). "[Clinical research about treatment for adrenal incidentalomas]". Zhonghua Wai Ke Za Zhi 46 (11): 832-4. PMID 19035218.
- ↑ Thompson, Lester D. R. (2006). Endocrine Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 200. ISBN 978-0443066856.
- ↑ IAV. 18 February 2009.
- ↑ Jain M, Kapoor S, Mishra A, Gupta S, Agarwal A (2010). "Weiss criteria in large adrenocortical tumors: a validation study". Indian J Pathol Microbiol 53 (2): 222–6. doi:10.4103/0377-4929.64325. PMID 20551521.
- ↑ Weiss, LM. (Mar 1984). "Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors.". Am J Surg Pathol 8 (3): 163-9. PMID 6703192.
- ↑ 10.0 10.1 Jorda M, De MB, Nadji M (March 2002). "Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas". Appl. Immunohistochem. Mol. Morphol. 10 (1): 67–70. doi:10.1097/00129039-200203000-00012. PMID 11893039.